At Risk for Huntington's Disease

HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.

Showing posts with label Ionis Pharmaceuticals. Show all posts
Showing posts with label Ionis Pharmaceuticals. Show all posts
Sunday, September 16, 2018

Roche Phase 3 clinical trial for Huntington’s disease gene-silencing drug to enroll volunteers in early 2019

›
The major drug company Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic Phase 3 cl...
Thursday, April 26, 2018

New Ionis data show positive trends in clinical measures of Huntington’s disease drug trial volunteers

›
Exploratory analysis of new data showed positive trends in several clinical signs of Huntington’s disease in the recently concluded Ionis...
Wednesday, March 28, 2018

Roche gears up for pivotal Phase 3 Huntington’s disease gene-silencing clinical trial

›
Pharmaceutical giant Roche  – currently without a timeline, but mindful of the urgency – is gearing up for the pivotal Phase 3 clinical t...
7 comments:
Wednesday, March 14, 2018

In chronicling the quest to cure Huntington’s disease, a whirlwind of emotions

›
Covering the 13th Annual Huntington’s Disease Therapeutics Conference left me with immense hope about potential treatments but also,  as i...
2 comments:
›
Home
View web version

About Me

Gene Veritas
View my complete profile
Powered by Blogger.